AGP

Artia Global Partners Portfolio holdings

AUM $389M
This Quarter Return
-4.26%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$248M
AUM Growth
+$248M
Cap. Flow
-$66M
Cap. Flow %
-26.6%
Top 10 Hldgs %
65.48%
Holding
54
New
8
Increased
11
Reduced
3
Closed
19

Top Buys

1
ACLX icon
Arcellx
ACLX
$17.6M
2
MRUS icon
Merus
MRUS
$16.1M
3
NUVL icon
Nuvalent
NUVL
$14.8M
4
SLNO icon
Soleno Therapeutics
SLNO
$9.89M
5
JANX icon
Janux Therapeutics
JANX
$8.73M

Top Sells

1
LLY icon
Eli Lilly
LLY
$82M
2
NVO icon
Novo Nordisk
NVO
$46.6M
3
VKTX icon
Viking Therapeutics
VKTX
$17.8M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
$8.79M
5
AXSM icon
Axsome Therapeutics
AXSM
$7.89M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MREO
26
Mereo BioPharma
MREO
$281M
$1.47M 0.53%
421,359
– –
NAMS icon
27
NewAmsterdam Pharma
NAMS
$2.77B
$1.4M 0.5%
54,285
– –
CNTA
28
Centessa Pharmaceuticals
CNTA
$2.32B
$1.35M 0.48%
80,380
– –
CRL icon
29
Charles River Laboratories
CRL
$7.94B
$1.16M 0.42%
6,305
– –
TARS icon
30
Tarsus Pharmaceuticals
TARS
$2.47B
$1.15M 0.41%
+20,811
New +$1.15M
ASND icon
31
Ascendis Pharma
ASND
$12.1B
$1.02M 0.37%
7,440
– –
ANNX icon
32
Annexon
ANNX
$227M
$884K 0.32%
172,226
– –
TECX
33
Tectonic Therapeutic, Inc. Common Stock
TECX
$312M
$769K 0.27%
+16,650
New +$769K
XBI icon
34
SPDR S&P Biotech ETF
XBI
$5.25B
– –
0
– –
QTTB icon
35
Q32 Bio
QTTB
$20.9M
– –
-4,705
Closed -$210K
ALEC icon
36
Alector
ALEC
$262M
– –
-193,317
Closed -$901K
AXSM icon
37
Axsome Therapeutics
AXSM
$6.16B
– –
-87,848
Closed -$7.89M
CLDX icon
38
Celldex Therapeutics
CLDX
$1.46B
– –
-75,300
Closed -$2.56M
CRBP icon
39
Corbus Pharmaceuticals
CRBP
$119M
– –
-47,400
Closed -$978K
DYN icon
40
Dyne Therapeutics
DYN
$1.92B
– –
-119,488
Closed -$4.29M
EWTX icon
41
Edgewise Therapeutics
EWTX
$1.57B
– –
0
– –
IDYA icon
42
IDEAYA Biosciences
IDYA
$2.23B
– –
-62,992
Closed -$2M
IONS icon
43
Ionis Pharmaceuticals
IONS
$9.16B
– –
-30,479
Closed -$1.22M
IRON icon
44
Disc Medicine
IRON
$2.13B
– –
-13,440
Closed -$660K
KROS icon
45
Keros Therapeutics
KROS
$638M
– –
-20,000
Closed -$1.16M
KURA icon
46
Kura Oncology
KURA
$690M
– –
-57,178
Closed -$1.12M
LLY icon
47
Eli Lilly
LLY
$659B
– –
-92,593
Closed -$82M
LRMR icon
48
Larimar Therapeutics
LRMR
$318M
– –
-90,490
Closed -$593K
MDGL icon
49
Madrigal Pharmaceuticals
MDGL
$9.72B
– –
-1,557
Closed -$330K
SLN
50
Silence Therapeutics
SLN
$225M
– –
-52,476
Closed -$954K
1
2
3